Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Medical Oncology
•
Hematology
What are the scenarios where peripheral blood NGS testing may substitute for BM biopsy?
E.g. For a patient with pancytopenia would you defer BM biopsy if NGS is normal?
Related Questions
Do you prefer to use 7+3 or CPX-351 as standard induction therapy in younger patients with AML-MRC or t-AML?
How should community oncologists practically counsel patients with aggressive lymphomas on the potential treatment course as they move into 2L/3L therapies?
What is your preferred regimen for a patient with newly diagnosed high-risk MM, transplant-eligible, with pre-existing grade 1 peripheral neuropathy?
Do complex cytogenetics have any therapeutic or prognostic relevance in CLL?
How would you treat cold agglutinin disease secondary to underlying marginal zone lymphoma with only bone marrow involvement and no disease elsewhere?
Have you encountered acute kidney injury after starting eltrombopag for aplastic anemia as part of triple immunosuppressive regimen with ATG and cyclosporine?
How do you utilize immunoglobulin testing to affect treatment decisions in patients with myeloma?
How do you decide between treatment with ABVD vs A + AVD in a patient in their 70s with advanced stage 4 classical Hodgkin lymphoma?
How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?
Does the presence of osteoporosis change the extent of workup that should be performed for an older patient with otherwise serologically low-risk MGUS?